Dataset Information

Pharmacists' perceptions and attitudes toward drug importation into the State of Florida.

ABSTRACT:

Background

The Department of Health and Human Services and the Food and Drug Administration released the Safe Importation Action Plan in July 2020 detailing methods to import medicines from Canada to combat increasing drug costs. In November 2020, Florida became the first state in the United States to create and propose an importation plan from Canada. This study examines the proposal submitted by Florida, Florida pharmacists' perceptions of the program on patient safety, and Florida pharmacists' thoughts on the pharmacy operational impact.

Methods

This was a cross-sectional study utilizing an electronic questionnaire sent to pharmacist members of the Florida Pharmacy Association. The survey incorporated closed-ended and open-ended questions. The results from the study were reported and analyzed through descriptive statistics, qualitative and quantitative data.

Results

Two-hundred and forty-four pharmacists responded to the survey. Of those respondents, 25% stated they had no knowledge about Florida's drug importation plan. Less than 12% of respondents stated they would trust the safety and quality of imported medicines. Seventy percent of pharmacists expressed concerns regarding the changes required in pharmacy operations to increase medicine safety. About half of the respondents questioned whether this plan would promote cost-savings as intended.

Conclusion

Florida pharmacists believe the drug importation plan does not address all aspects of patient and medicine safety and expressed concerns regarding logistical operations of a pharmacy. This article highlights those concerns and acts as a summons to action.

SUBMITTER: Hertig JB

PROVIDER: S-EPMC8638520 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:BackgroundThe pharmacy profession has changed enormously in the recent decades. Pharmacist role has been expanded beyond formulating and dispensing medications to include the provision of pharmaceutical care and public health services to patients. Patient-centred care requires sustained competency through improving pharmacist's knowledge, skills, and performance. Such improvements require pharmacist's involvement in continuing education activities although it is optional in Kuwait.ObjectiveTo explore pharmacists' attitudes towards continuing education in Kuwait, and to investigate the perceived barriers that hinder pharmacists from being involved in continuing education activities.Setting.All governmental hospitals and polyclinics and private pharmacies in all the five health regions of Kuwait (Capital, Hawalli, Ahmadai, Farwaniyah, and Jahra).MethodA descriptive cross-sectional study conducted with full licensed pharmacists working in Kuwait. Pharmacists were asked to complete an adapted validated questionnaire composed of 14 items to measure their attitudes towards continuing education. In addition, it contains open-ended questions to obtain the type of learning activity undertaken by the pharmacists, and whether they have barriers that hinder them from being involved in continuing education.ResultsA total of 409 pharmacists completed the questionnaire. The participants had a median score of 44 (interquartile range = 41-47); good to excellent attitudes. Attitude scores were correlated with age and years of experience. Almost 70% of the participants had attended a continuing education activity within one year. The activity undertaken most by pharmacists was attending a seminar, compared to other activities. The main barriers to continuing education were lack of personal time (n = 383), lack of scientific databases and books (n = 187) and conferences are not regularly organized locally (n = 154).ConclusionPharmacists in Kuwait have positive attitudes towards continuing education overall. However, there are many obstacles that avert pharmacists to practice continuing education. Further studies are required to explore how to overcome the reported barriers and provide more feasible and relevant continuing education to pharmacists.